文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host.

作者信息

Tang Haijun, Shao Yun, Huang Yi, Qiao Shigang, An Jianzhong, Yan Ruhong, Zhao Xin, Meng Fang, Du Xiaohong, Qin F Xiao-Feng

机构信息

Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College; Suzhou Institute of Systems Medicine, Suzhou, 215123, China.

Shengli Clinical Medical College, Fujian Medical University; Center for Experimental Research in Clinical Medicine, Fujian Provincial Hospital, Fuzhou, 350001, China.

出版信息

Signal Transduct Target Ther. 2023 May 23;8(1):211. doi: 10.1038/s41392-023-01449-w.

DOI:10.1038/s41392-023-01449-w
PMID:37221221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10204007/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/10205755/1a77868b424c/41392_2023_1449_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/10205755/1a77868b424c/41392_2023_1449_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/10205755/1a77868b424c/41392_2023_1449_Fig1_HTML.jpg

相似文献

[1]
Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host.

Signal Transduct Target Ther. 2023-5-23

[2]
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.

Emerg Microbes Infect. 2023-12

[3]
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.

Cell Host Microbe. 2023-1-11

[4]
Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.

Emerg Infect Dis. 2022-11

[5]
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.

Genome Med. 2022-12-29

[6]
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.

Vaccine. 2023-3-24

[7]
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals.

Vaccine. 2023-1-23

[8]
Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis.

J Clin Virol. 2023-3

[9]
Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.

Signal Transduct Target Ther. 2023-4-17

[10]
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.

JAMA Netw Open. 2022-10-3

引用本文的文献

[1]
Monitoring SARS-CoV-2 Dissemination in Wastewater and Virus Isolation in Cell Cultures: An Integrated Approach for Pathogen Detection and Surveillance.

J Cell Mol Med. 2025-9

[2]
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.

J Virol. 2025-6-17

[3]
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.

medRxiv. 2025-3-7

[4]
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

BMC Infect Dis. 2024-12-28

[5]
CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis.

Endocrine. 2024-9

[6]
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.

Front Microbiol. 2023-11-23

[7]
Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.

Res Sq. 2023-10-27

本文引用的文献

[1]
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.

Cell Host Microbe. 2022-9-14

[2]
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.

Nature. 2022-8

[3]
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.

Nature. 2022-8

[4]
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.

Signal Transduct Target Ther. 2022-3-9

[5]
Omicron adopts a different strategy from Delta and other variants to adapt to host.

Signal Transduct Target Ther. 2022-2-10

[6]
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.

Nature. 2022-3

[7]
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.

Nature. 2022-3

[8]
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.

Nature. 2022-3

[9]
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.

Emerg Microbes Infect. 2022-12

[10]
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.

Signal Transduct Target Ther. 2020-6-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索